Peyton Greenside, co-founder and CEO of BigHat Biosciences, on machine-learning guided biologic drug discovery.

Ep178: Peyton Greenside on ML-Guided Biologics Discovery

"The Long Run"

Antarctic explorer Ernest Shackleton would appreciate today's biotech. Scientific entrepreneurs of the 21st century must be ready for what Shackleton called the “hazardous journey, bitter cold, long months of complete darkness, constant danger, safe return doubtful, honor and recognition in case of success.” Today, the men and women who strive to apply science for the betterment of human health have a historic opportunity. They need stamina and resilience to achieve something meaningful. Biotech’s relationship with the society that sustains it has never been more tenuous. 

Join host Luke Timmerman for in-depth, thought-provoking conversations with biotech newsmakers pursuing these great opportunities of the 21st century.

Science

"The Long Run" Antarctic explorer Ernest Shackleton would appreciate today's biotech. Scientific entrepreneurs of the 21st century must be ready for what Shackleton called the “hazardous journey, bitter cold, long months of complete darkness, constant danger, safe return doubtful, honor and recognition in case of success.” Today, the men and women who strive to apply science for the betterment of human health have a historic opportunity. They need stamina and resilience to achieve something meaningful. Biotech’s relationship with the society that sustains it has never been more tenuous. Join host Luke Timmerman for in-depth, thought-provoking conversations with biotech newsmakers pursuing these great opportunities of the 21st century.

Share Ep178: Peyton Greenside on ML-Guided Biologics Discovery

Sign up to save your podcasts

Ep178: Peyton Greenside on ML-Guided Biologics Discovery

Ep178: Peyton Greenside on ML-Guided Biologics Discovery

More shows like The Long Run with Luke Timmerman

Planet Money

Freakonomics Radio

POP | TECH | JAM

Masters in Business

a16z Podcast

About Men Radio

Odd Lots

Strings and Things

Invest Like the Best with Patrick O'Shaughnessy

The Workup

Immune

The Readout Loud

The Journal.

Biotech 2050 Podcast

Business Of Biotech

BioCentury This Week

Raising Health

Night Science

Biotech Hangout